Literature DB >> 26124271

PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function.

Ying Chen1, Hai-Sheng Zhang1, Guo-Hua Fong2, Qiu-Lei Xi3, Guo-Hao Wu3, Chen-Guang Bai4, Zhi-Qiang Ling5, Li Fan1, Yi-Ming Xu1, Yan-Qing Qin1, Tang-Long Yuan1, Heng Sun1, Jing Fang6.   

Abstract

Prolyl hydroxylase domain proteins (PHDs) control cellular adaptation to hypoxia. PHDs are found involved in inflammatory bowel disease (IBD); however, the exact role of PHD3, a member of the PHD family, in IBD remains unknown. We show here that PHD3 plays a critical role in maintaining intestinal epithelial barrier function. We found that genetic ablation of Phd3 in intestinal epithelial cells led to spontaneous colitis in mice. Deletion of PHD3 decreases the level of tight junction protein occludin, leading to a failure of intestinal epithelial barrier function. Further studies indicate that PHD3 stabilizes occludin by preventing the interaction between the E3 ligase Itch and occludin, in a hydroxylase-independent manner. Examination of biopsy of human ulcerative colitis patients indicates that PHD3 is decreased with disease severity, indicating that PHD3 down-regulation is associated with progression of this disease. We show that PHD3 protects intestinal epithelial barrier function and reveal a hydroxylase-independent function of PHD3 in stabilizing occludin. These findings may help open avenues for developing a therapeutic strategy for IBD.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell biology; colitis; inflammatory bowel disease (IBD); intestinal epithelium; occludin; prolyl hydroxylase; tight junction

Mesh:

Substances:

Year:  2015        PMID: 26124271      PMCID: PMC4536461          DOI: 10.1074/jbc.M115.653584

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Complex phenotype of mice lacking occludin, a component of tight junction strands.

Authors:  M Saitou; M Furuse; H Sasaki; J D Schulzke; M Fromm; H Takano; T Noda; S Tsukita
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

2.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

3.  The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch.

Authors:  Andreas Traweger; Deyu Fang; Yun-Cai Liu; Wolfgang Stelzhammer; Istvan A Krizbai; Fritz Fresser; Hans-Christian Bauer; Hannelore Bauer
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

4.  Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.

Authors:  Jörn Karhausen; Glenn T Furuta; John E Tomaszewski; Randall S Johnson; Sean P Colgan; Volker H Haase
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

5.  Adhesion molecules in inflammatory bowel disease.

Authors:  S C Jones; R E Banks; A Haidar; A J Gearing; I K Hemingway; S H Ibbotson; M F Dixon; A T Axon
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

6.  Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.

Authors:  Rebecca J Appelhoff; Ya-Min Tian; Raju R Raval; Helen Turley; Adrian L Harris; Christopher W Pugh; Peter J Ratcliffe; Jonathan M Gleadle
Journal:  J Biol Chem       Date:  2004-07-07       Impact factor: 5.157

7.  Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.

Authors:  Jing Xue; Xuebing Li; Shi Jiao; Ye Wei; Guohao Wu; Jing Fang
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

Review 8.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

9.  Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.

Authors:  G T Furuta; J R Turner; C T Taylor; R M Hershberg; K Comerford; S Narravula; D K Podolsky; S P Colgan
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

Review 10.  Oxygen sensing by HIF hydroxylases.

Authors:  Christopher J Schofield; Peter J Ratcliffe
Journal:  Nat Rev Mol Cell Biol       Date:  2004-05       Impact factor: 94.444

View more
  21 in total

Review 1.  The role of mucosal barriers in human gut health.

Authors:  Kangseok Seo; Jeongmi Seo; Jiyoun Yeun; Haebin Choi; Young-In Kim; Sun-Young Chang
Journal:  Arch Pharm Res       Date:  2021-04-22       Impact factor: 4.946

2.  The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression.

Authors:  Vikash Singh; Chethana P Gowda; Vishal Singh; Ashwinkumar S Ganapathy; Dipti M Karamchandani; Melanie A Eshelman; Gregory S Yochum; Prashant Nighot; Vladimir S Spiegelman
Journal:  J Biol Chem       Date:  2020-05-08       Impact factor: 5.157

3.  PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.

Authors:  Zachary R Schoepflin; Elizabeth S Silagi; Irving M Shapiro; Makarand V Risbud
Journal:  FASEB J       Date:  2017-05-11       Impact factor: 5.191

4.  Peroxisome Proliferator-activated Receptor-γ Coactivator 1-α (PGC1α) Protects against Experimental Murine Colitis.

Authors:  Kellie E Cunningham; Garret Vincent; Chhinder P Sodhi; Elizabeth A Novak; Sarangarajan Ranganathan; Charlotte E Egan; Donna Beer Stolz; Matthew B Rogers; Brian Firek; Michael J Morowitz; George K Gittes; Brian S Zuckerbraun; David J Hackam; Kevin P Mollen
Journal:  J Biol Chem       Date:  2016-03-11       Impact factor: 5.157

5.  Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.

Authors:  Yiming Xu; Qiang Gao; Yaqian Xue; Xiuxiu Li; Liang Xu; Chenwei Li; Yanqing Qin; Jing Fang
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

Review 6.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

Review 7.  Hypoxia-dependent regulation of inflammatory pathways in immune cells.

Authors:  Cormac T Taylor; Glen Doherty; Padraic G Fallon; Eoin P Cummins
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

8.  SLC26A3 (DRA) prevents TNF-alpha-induced barrier dysfunction and dextran sulfate sodium-induced acute colitis.

Authors:  Xiangming Ding; Dongxiao Li; Mengke Li; Han Wang; Qin He; Yunwu Wang; Hongbing Yu; Dean Tian; Qin Yu
Journal:  Lab Invest       Date:  2018-01-12       Impact factor: 5.662

9.  Prolyl hydroxylase 3 controls the intestine goblet cell generation through stabilizing ATOH1.

Authors:  Yi-Ming Xu; Qiang Gao; Jin-Zhao Zhang; Yun-Tao Lu; Dong-Ming Xing; Yan-Qing Qin; Jing Fang
Journal:  Cell Death Differ       Date:  2020-01-20       Impact factor: 15.828

Review 10.  Endocytosis of Intestinal Tight Junction Proteins: In Time and Space.

Authors:  Prashant Nighot; Thomas Ma
Journal:  Inflamm Bowel Dis       Date:  2021-01-19       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.